SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ore Pharmaceuticals Inc.
ORXE 0.193+1.8%Aug 18 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (7)3/15/2008 2:23:17 PM
From: Mike McFarlandRead Replies (1) of 50
 
WHEREAS, following the sale of the Company's Genomics
Division, Miller and the Board were unable to reach agreement
on the future direction of the Company


That seems unlikely--I wonder why they put that in
there? Even the casual observer like myself has a pretty
good feeling for why genomics was a bust.

I have a guess: The DR was a bust and Miller knows that
and he got out. Time will tell, but right now my $1.45
shares are trading for 50 cents, I guess I'd rather have
70 cents--makes you wonder if we are ever likely to see
more than that price again. Why sell out for 70 cents
if more is possible?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext